387 related articles for article (PubMed ID: 26273061)
1. Comparison of long-term outcomes between children with aplastic anemia and refractory cytopenia of childhood who received immunosuppressive therapy with antithymocyte globulin and cyclosporine.
Hama A; Takahashi Y; Muramatsu H; Ito M; Narita A; Kosaka Y; Tsuchida M; Kobayashi R; Ito E; Yabe H; Ohga S; Ohara A; Kojima S
Haematologica; 2015 Nov; 100(11):1426-33. PubMed ID: 26273061
[TBL] [Abstract][Full Text] [Related]
2. [Immunosuppressive therapy using antithymocyte globulin and cyclosporin A with or without human granulocyte colony-stimulating factor in children with acquired severe aplastic anemia].
Liu X; Zou Y; Wang S; Zhang L; Yang W; Zhang J; Liu F; Liu T; Chen X; Ruan M; Zhou J; Cai X; Qi B; Chang L; An W; Guo Y; Chen Y; Zhu X
Zhonghua Er Ke Za Zhi; 2014 Feb; 52(2):84-9. PubMed ID: 24739716
[TBL] [Abstract][Full Text] [Related]
3. Immunosuppressive therapy using antithymocyte globulin, cyclosporine, and danazol with or without human granulocyte colony-stimulating factor in children with acquired aplastic anemia.
Kojima S; Hibi S; Kosaka Y; Yamamoto M; Tsuchida M; Mugishima H; Sugita K; Yabe H; Ohara A; Tsukimoto I
Blood; 2000 Sep; 96(6):2049-54. PubMed ID: 10979946
[TBL] [Abstract][Full Text] [Related]
4. Myelodysplastic syndrome and acute myelogenous leukemia as a late clonal complication in children with acquired aplastic anemia.
Ohara A; Kojima S; Hamajima N; Tsuchida M; Imashuku S; Ohta S; Sasaki H; Okamura J; Sugita K; Kigasawa H; Kiriyama Y; Akatsuka J; Tsukimoto I
Blood; 1997 Aug; 90(3):1009-13. PubMed ID: 9242530
[TBL] [Abstract][Full Text] [Related]
5. [Clinical features of cytopenia with bone marrow hypoplasia in children: an analysis of 100 cases].
Yang WY; Chen XJ; Zhang PH; Hama A; Ito M; Kojima S; Zhu XF
Zhongguo Dang Dai Er Ke Za Zhi; 2013 Jun; 15(6):448-52. PubMed ID: 23791060
[TBL] [Abstract][Full Text] [Related]
6. Risk factors for evolution of acquired aplastic anemia into myelodysplastic syndrome and acute myeloid leukemia after immunosuppressive therapy in children.
Kojima S; Ohara A; Tsuchida M; Kudoh T; Hanada R; Okimoto Y; Kaneko T; Takano T; Ikuta K; Tsukimoto I;
Blood; 2002 Aug; 100(3):786-90. PubMed ID: 12130487
[TBL] [Abstract][Full Text] [Related]
7. [Efficacy of immunosuppressive therapy for children with aplastic anemia].
Wang YC; Yin CY; Feng L; Wang CM; Ma LN; Wei YW; Sheng GY
Zhongguo Dang Dai Er Ke Za Zhi; 2012 Jan; 14(1):33-7. PubMed ID: 22289749
[TBL] [Abstract][Full Text] [Related]
8. [Myelodysplastic syndrome with monosomy 7 following combination therapy with granulocyte colony-stimulating factor, cyclosporin A and danazole in an adult patient with severe aplastic anemia].
Tsuzuki M; Okamoto M; Yamaguchi T; Ino T; Ezaki K; Hirano M
Rinsho Ketsueki; 1997 Sep; 38(9):745-51. PubMed ID: 9364865
[TBL] [Abstract][Full Text] [Related]
9. Comparison of immune manifestations between refractory cytopenia of childhood and aplastic anemia in children: A single-center retrospective study.
Wu J; Cheng Y; Zhang L
Leuk Res; 2015 Dec; 39(12):1347-52. PubMed ID: 26427728
[TBL] [Abstract][Full Text] [Related]
10. [Immunosuppressive therapy for 54 children patients with acquired severe aplastic anemia].
Chen C; Fang JP; Huang SL; Zhong FY
Zhonghua Er Ke Za Zhi; 2006 Nov; 44(11):841-4. PubMed ID: 17274875
[TBL] [Abstract][Full Text] [Related]
11. Immunosuppressive therapy for pediatric aplastic anemia: a North American Pediatric Aplastic Anemia Consortium study.
Rogers ZR; Nakano TA; Olson TS; Bertuch AA; Wang W; Gillio A; Coates TD; Chawla A; Castillo P; Kurre P; Gamper C; Bennett CM; Joshi S; Geddis AE; Boklan J; Nalepa G; Rothman JA; Huang JN; Kupfer GM; Cada M; Glader B; Walkovich KJ; Thompson AA; Hanna R; Vlachos A; Malsch M; Weller EA; Williams DA; Shimamura A
Haematologica; 2019 Oct; 104(10):1974-1983. PubMed ID: 30948484
[TBL] [Abstract][Full Text] [Related]
12. Multicenter prospective study of clonal complications in adult aplastic anemia patients following recombinant human granulocyte colony-stimulating factor (lenograstim) administration.
Bessho M; Hotta T; Ohyashiki K; Takahashi T; Mizoguchi H; Asano S; Ikeda Y; Sakurai M; Tojo A; Kizaki M; Iwanaga M; Tomonaga M; Hirashima K
Int J Hematol; 2003 Feb; 77(2):152-8. PubMed ID: 12627850
[TBL] [Abstract][Full Text] [Related]
13. Successful bone marrow plus cord blood stem cell transplantation in a girl who developed myelodysplastic syndrome from hepatitis-associated aplastic anemia treated with long-term immunosuppressants and growth factors.
Shibuya A; Ishii S; Obinata K
Hematology; 2002 Oct; 7(5):301-4. PubMed ID: 12850817
[TBL] [Abstract][Full Text] [Related]
14. Detection of myelodysplastic syndrome/ acute myeloid leukemia evolving from aplastic anemia in children, treated with recombinant human G-CSF.
Imashuku S; Hibi S; Bessho F; Tsuchida M; Nakahata T; Miyazaki S; Tsukimoto I; Hamajima N;
Haematologica; 2003 Nov; 88(11):ECR31. PubMed ID: 14607763
[TBL] [Abstract][Full Text] [Related]
15. Antithymocyte globulin and cyclosporine in children with aplastic anemia: a developing country experience.
Sharma R; Chandra J; Sharma S; Pemde H; Singh V
J Pediatr Hematol Oncol; 2012 Mar; 34(2):93-5. PubMed ID: 22278201
[TBL] [Abstract][Full Text] [Related]
16. Antilymphocyte globulin, cyclosporine, prednisolone, and granulocyte colony-stimulating factor for severe aplastic anemia: an update of the GITMO/EBMT study on 100 patients. European Group for Blood and Marrow Transplantation (EBMT) Working Party on Severe Aplastic Anemia and the Gruppo Italiano Trapianti di Midolio Osseo (GITMO).
Bacigalupo A; Bruno B; Saracco P; Di Bona E; Locasciulli A; Locatelli F; Gabbas A; Dufour C; Arcese W; Testi G; Broccia G; Carotenuto M; Coser P; Barbui T; Leoni P; Ferster A
Blood; 2000 Mar; 95(6):1931-4. PubMed ID: 10706857
[TBL] [Abstract][Full Text] [Related]
17. Antithymocyte globulin and cyclosporine for severe aplastic anemia: association between hematologic response and long-term outcome.
Rosenfeld S; Follmann D; Nunez O; Young NS
JAMA; 2003 Mar; 289(9):1130-5. PubMed ID: 12622583
[TBL] [Abstract][Full Text] [Related]
18. Long-term outcome of a randomized controlled study in patients with newly diagnosed severe aplastic anemia treated with antithymocyte globulin and cyclosporine, with or without granulocyte colony-stimulating factor: a Severe Aplastic Anemia Working Party Trial from the European Group of Blood and Marrow Transplantation.
Tichelli A; de Latour RP; Passweg J; Knol-Bout C; Socié G; Marsh J; Schrezenmeier H; Höchsmann B; Bacigalupo A; Samarasinghe S; Rovó A; Kulasekararaj A; Röth A; Eikema DJ; Bosman P; Bader P; Risitano A; Dufour C;
Haematologica; 2020 May; 105(5):1223-1231. PubMed ID: 31582549
[TBL] [Abstract][Full Text] [Related]
19. Rabbit antithymocyte globulin treatment in childhood acquired severe aplastic anemia.
Karapinar DY; Karadaş N; Ay Y; Akin M; Balkan C; Aydinok Y; Kavakli K
Pediatr Hematol Oncol; 2014 Feb; 31(1):20-8. PubMed ID: 23627541
[TBL] [Abstract][Full Text] [Related]
20. Relapse and clonal disease in children with aplastic anemia (AA) after immunosuppressive therapy (IST): the SAA 94 experience. German/Austrian Pediatric Aplastic Anemia Working Group.
Führer M; Burdach S; Ebell W; Gadner H; Haas R; Harbott J; Janka-Schaub G; Klingebiel T; Kremens B; Niemeyer C; Rampf U; Reiter A; Ritter J; Schulz A; Walther U; Zeidler C; Bender-Götze C
Klin Padiatr; 1998; 210(4):173-9. PubMed ID: 9743949
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
